In cytotoxicity assays, treatment with both JAKi significantly decreased the killing ability of NK cells against carcinoma cells (Fig. 6c), indicating that JAK/STAT pathway inhibition impairs the anti-tumour potential of NK cells. The gene discussed is SOAT1; the disease is carcinoma.